[ad_1]
Forty percent of this week’s coronavirus cases were from Florida, Texas and Missouri, White House COVID-19 response coordinator Jeff Zients said. Florida contributed the most cases with one in five infections coming from the state alone.
The news comes as the highly transmissible delta variant is believed to account for 83% of infections in the United States and is responsible for the increase in cases nationwide, with unvaccinated people accounting for nearly all hospitalizations and deaths. CDC director Dr Rochelle Walensky noted 46,318 daily cases reported to the CDC, the seven-day average leading up to July 20 at 37,674, reflecting a 52.5% increase from the previous week.
Zients also noted that the states with the highest number of cases, such as Arkansas, Florida, Louisiana and Nevada, had a rate of newly vaccinated residents higher than the national average.
“People in these states are feeling the impact of not being vaccinated and are responding with action,” Zients said.
CDC: DELTA VARIANT REPRESENTS 83% OF CASES IN THE UNITED STATES
About 162 million Americans have been fully immunized, including 80% of those most at risk for poor COVID-19 outcomes.
THE BENEFITS OF THE J&J COVID-19 VACCINE IS “MUCH HIGHER”, SAYS CDC PANEL AFTER GUILLAIN-BARRÉ SYNDROME REPORTS
About 2 million people have received an injection in the past 10 days.
Surgeon General Dr Vivek Murthy stressed the importance of getting vaccinated, noting that 99.5% of deaths from COVID-19 are among the unvaccinated as well as 97% of all hospitalizations.
CLICK HERE TO GET THE FOX NEWS APP
Vivek also addressed disinformation, mostly found on social media, which he said “is a threat to our health and the speed, scale and sophistication with which it is spread is unprecedented,” citing the advisory. which he published last week in an attempt to combat disinformation.
President Biden predicted vaccines could get clearance for children under 12 as early as August, with Walenksy adding, “I’ll just say we’re looking at clinical trial data now, we’re waiting for clinical trial data to arrive. , data approval and clearance will be a regulatory decision of the FDA. So after we saw the clinical trial I haven’t seen them myself, after we see them they will go to the FDA for their regulatory clearance process. “
[ad_2]
Source link